OrganiGram vs Canopy Growth Which Performs Better?

OrganiGram and Canopy Growth are two of the biggest players in the cannabis industry, both offering investors the opportunity to capitalize on the rapidly growing market for legal marijuana products. While Canopy Growth is a well-established global leader, OrganiGram is a smaller but rapidly expanding company with a focus on high-quality, organic cannabis products. Investors looking to bet on the future of the cannabis industry have a choice between these two stocks, each offering unique opportunities and challenges.

OrganiGram or Canopy Growth?

When comparing OrganiGram and Canopy Growth, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between OrganiGram and Canopy Growth.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. OrganiGram has a dividend yield of -%, while Canopy Growth has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. OrganiGram reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Canopy Growth reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with OrganiGram P/E ratio at -3.09 and Canopy Growth's P/E ratio at -0.69. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. OrganiGram P/B ratio is 0.76 while Canopy Growth's P/B ratio is 0.69.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, OrganiGram has seen a 5-year revenue growth of 3.45%, while Canopy Growth's is 4.92%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with OrganiGram's ROE at -26.61% and Canopy Growth's ROE at -111.67%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $1.52 for OrganiGram and $3.85 for Canopy Growth. Over the past year, OrganiGram's prices ranged from $1.14 to $2.91, with a yearly change of 155.26%. Canopy Growth's prices fluctuated between $2.75 and $14.92, with a yearly change of 441.56%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.